You are viewing an inactive listing

Rochester, Minnesota 55905

  • Arthrofibrosis


This research is being done to see if the amount of an enzyme in blood (called serum mast cell tryptase) changes before and after surgery. The investigators would like to see if these amounts are related to knee stiffness and pain in subjects that undergo a total knee replacement.


Inclusion Criteria: - Investigators will include all patients with osteoarthritis who are surgical candidates for primary TKA. Investigators will include all eligible male or female patients between the ages of 20 years to 100 years old. All included study participants must be able to give an informed consent. Exclusion Criteria: - Significant femoral or tibial deformity due to congenital or traumatic etiologies, inflammatory arthritis, post-septic arthritis, osteomyelitis, prior infection of knee joint, osteoporosis, dislocated or fragmented patella - Patients taking mast cell inhibitors and/or degranulation inhibitors for any reason. - The presence of infections, highly communicable diseases (e.g. AIDS), active tuberculosis, venereal disease, hepatitis. - Significant neurological or musculoskeletal disorders or disease that may adversely affect normal gait or weight bearing. - Presence of previous prosthetic knee replacement devices (of any type) - Metastatic disease - Psychiatric illness - Drug or alcohol abuse - Inability to participate in standard postoperative rehabilitation protocol



Primary Contact:

Principal Investigator
Matthew Abdel, M.D.
Mayo Clinic

Backup Contact:


Location Contact:

Rochester, Minnesota 55905
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: June 21, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.